Maximum quantity allowed is 999
CAS RN: 905459-27-0 | 产品编码: R0321
[1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) Dichloride (HPMC encapsulated)
palladium(II) Dichloride (HPMC encapsulated) Chemical Structure of [1,3-Bis(2,6-diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) Dichloride (HPMC encapsulated)](/medias/Tci-440-R0321.jpg?context=bWFzdGVyfHJvb3R8MzI4NzV8aW1hZ2UvanBlZ3xhR0U1TDJobU1TODVOVE16TURVNU5EazRNREUwTDFSamFTMDBOREJmVWpBek1qRXVhbkJufDg4MTU0ODk4ZDMyZTU3NTExZmQ3YjE4MmQyYWY5ZjI0M2QzYWQzNWE0MDQ5NWUwMDlkNTM4NGE1Y2YyYzVlOWM)
补充产品信息:
This product is unavailable in the U.S.
Contents (per one capsule)
- [1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) Dichloride ca. 0.060 mmol
Uses of Reagent
- Applicable to palladium-catalyzed reactions due to a palladium catalyst encapsulated in HPMC capsules
Soluble Solvents
- Water, DMSO, DMF, 1,4-Dioxane (50°C), THF/Water mixture, 1,2-Dimethoxyethane/Water mixture
Related Product
- B6199 [1,3-Bis(2,6-Diisopropylphenyl)imidazol-2-ylidene](3-chloropyridyl)palladium(II) Dichloride
产品编码 | R0321 |
分子式/分子量 | C__3__2H__4__0Cl__3N__3Pd = 679.46 |
外观与形状(20°C) | 固体 |
储存温度 ![]() |
室温 (15°C以下阴凉干燥处) |
储存在惰性气体下 | 存放于惰性气体之中 |
应避免的情况 | 空气 |
CAS RN | 905459-27-0 |
Appearance | White to Almost white capsule |
Functionality test (conversion ratio) | min.90.0 % |
HS编码* | 3822.19-000 |
-
Used Chemicals
-
Procedure
-
Organ's catalyst (HPMC encapsulated) (one capsule) was added to a solution of 2-acetamido-5-bromo-4-methylpyridine (275 mg, 1.20 mmol), cesium carbonate (430 mg, 1.32 mmol, 1.1 eq.) and phenylboronic acid (220 mg, 1.8 mmol, 1.5 eq.) in THF/water (4:1, 5 mL) at room temperature and the reaction mixture was stirred at 100 °C for 2 hours. The solution was then diluted with ethyl acetate (10 mL) and sat. Na2SO4 aq. (10 mL), and filtered through Celite pad and the filtrate was extracted with ethyl acetate (10 mL x 2). The organic layer was washed with water (10 mL) and brine (10 mL), dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by silica gel chromatography (ethyl acetate:hexane = 1:2 - 4:1) and then further purified by reversed-phase silica gel chromatography (water:acetonitrile = 95:5 - 40:60) to afford 2-acetamido-4-methyl-5-phenylpyridine (227 mg, 84% yield) as a white solid.
-
Experimenter’s Comments
-
The reaction mixture was monitored by GC.
The silica gel column purification failed to separate the debromo compound. Therefore, the purification was also performed on an ODS column.
The material of the capsule is water-soluble HPMC (hydroxypropyl methylcellulose).
The shape of the capsule is like the image below and Organ’s catalyst (ca. 60 μmol) is encapsulated in each capsule.
The capsule disintegrates as shown in the image below when stirred in the solvent for about 15 minutes, releasing its content.
-
Analytical Data
-
2-Acetamido-4-methyl-5-phenylpyridine
1H NMR (400 MHz, CDCl3); δ 9.24-9.06 (brs, 1H), 8.16 (s, 1H), 8.10 (s, 1H), 7.46-7.36 (m, 3H), 7.30-7.29 (m, 2H), 2.32 (s, 3H), 2.21 (s, 3H).
-
Lead Reference
-
- Reagent and Catalyst Capsules: A Chemical Delivery System for Reaction Screening and Parallel Synthesis
-
Other References
-
- HPMC: A Biomass-Based Semisynthetic Sustainable Additive Enabling Clean and Fast Chemistry in Water
化学品安全说明书(SDS)
如需更多帮助,请联系我 们。
技术规格
CoA及其他文档
示例 CoA
目前没有该产品的 CoA 示例。
分析图谱
很抱歉,您搜索的分析图谱无法提供。